PELP1 was localized to the cytoplasm in 36% of RPFNA samples from women at high-risk for developing breast cancer, and our in vitro findings show that cytoplasmic PELP1 localization promotes HMEC survival in response to Tam. Here, PELP1 is linked to breast cancer.